Long acting beta agonist in EIB

Effect of a single dose of the long-acting beta agonist salmeterol versus placebo in exercise induced bronchoconstriction. Salmeterol, but not placebo, protected against a decline in FEV1 with exercise. This effect was seen at both one (left panel) and nine (right panel) hours.